Skip to content

Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics

Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02769585
Enrollment
74
Registered
2016-05-11
Start date
2013-07-31
Completion date
2015-04-30
Last updated
2016-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Obesity, Weight Reduction

Keywords

Obesity, Diabetes Mellitus, Type 2, weight reduction

Brief summary

Randomized study evaluating self-hypnosis versus certified diabetes educator training for weight loss in type 2 diabetics.

Detailed description

Study Subjects: Approximately 74 type II diabetics will be randomized. Key inclusion criteria: overweight (BMI≥25), motivated to lose weight, and are at least 18 years of age. Key exclusion criteria: pregnant women or women of childbearing age, currently taking medications for weight loss, enrolled in another clinical trial, or planning on having bariatric surgery. Any patient who is taking medication prescribed by a physician for depression, anxiety, or any other psychiatric disorder will be excluded. Patients on glucocorticoids in excess of Prednisone 7.5 mg or equivalent will also be excluded. Study Design: All patients who pass screening will be administered the IPQ Test®\[6\]. This test stratifies patients on how they use their imagination, an important factor necessary to reach their goals. This is predictive of their potential to persist toward agreed upon goals. Patients will be divided into groups as follows: (Raw score 49-96 = high responders; Raw score 0-48 = Low responders). Ultimately, subjects will be divided into four groups: The assignment of high versus low responders will be based on the results of the IPQ® test. Subjects will then be randomly assigned to intervention versus control in a 1:1 fashion. Optimally, there should be equal numbers in each group; however, the group sizes may be unequal depending on the relative proportions of high versus low responders. The four groups will be as follows: Group I (high responders) will receive self-hypnosis using the GIFT™ (Goal Image Focusing Technique)\[7\] as the main means of autosuggestion and self/group motivation to lose weight. Group II (low responders) will receive self-hypnosis (without the GIFT™ system) and self/group motivation to lose weight. Group III (high responders) will receive standard nutrition, diet, and exercise counseling by a CDE (Certified Diabetes Educator) to serve as a control group for Group I. Group IV (low responders) will receive standard nutrition, diet, and exercise counseling by a CDE (Certified Diabetes Educator) to serve as a control for group II.

Interventions

BEHAVIORALSelf-hypnosis

Self-hypnosis

BEHAVIORALCDE training

standard CDE training for an obese diabetic

Sponsors

Levenson, David I., M.D.
Lead SponsorINDIV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Type 2 Diabetes * BMI greater than 25

Exclusion criteria

* pregnant women of of childbearing age * currently taking weight loss medications * enrolled in another clinical trial * currently taking medications for depression or anxiety * currently taking Prednisone \>7.5 mg day

Design outcomes

Primary

MeasureTime frameDescription
Change in weight (BMI)one yearComparison of subject's weight (BMI) from screening visit to last study visit.

Secondary

MeasureTime frameDescription
hemoglobin A1cone yearchange in Hgb A1c from screening to last study visit
fasting glucoseone yearchange in fasting glucose from screening visit to last study visit
High versus low imageryone yearComparison of subjects who scored high (\>=48) or low (\<= 47) on the IPQ questionnaire which was administered at the screening visit to all subjects. IPQ test can be found here Harte, Richard and Coller, Alan R. The Harte Coller IPQ® Inventory, Experimental Form E, New York/ The Harte Center for Hypnosis, 1986.
Waist circumferenceOne yearchange in waist circumference from screening visit to last study date
Reproducibility of IPQone yearCompare results of IPQ test administered at screening with identical test administered at final study visit one year later. To assess how many subjects changed categorization between high (\>=48) or low (\<=47) responders. Information on IPQ can be found here: Harte, Richard and Coller, Alan R. The Harte Coller IPQ® Inventory, Experimental Form E, New York/ The Harte Center for Hypnosis, 1986.
Degree of weight loss in obese versus overweightone yearDetermine if starting BMI influenced degree of weight loss.
Complianceone yearAssess whether self-reported adherence with the treatment (self-hypnosis or CDE) influenced degree of weight loss

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026